Is it morally acceptable to use gene editing technologies on humans?

Opening Statement

Affirmative Opening Statement

Ladies and gentlemen, esteemed judges, we stand firmly on the side of progress, compassion, and human agency. We affirm that it is not only morally acceptable but morally imperative to use gene editing technologies on humans—when applied responsibly, ethically, and with the aim of alleviating suffering and expanding human potential.

First, consider the moral duty to prevent disease. Gene editing offers us an unprecedented opportunity to eliminate hereditary conditions like cystic fibrosis, Huntington’s disease, and sickle cell anemia before birth. If we possess the power to stop children from enduring lifelong pain—and we do—is it not our ethical obligation to act? To withhold this technology would be akin to refusing vaccines in the early 20th century: well-intentioned fear leading to unnecessary suffering.

Second, autonomy matters. Parents already make profound decisions about their children’s futures—from nutrition to education. Why should they be denied the right to protect their offspring from genetic disorders using safe, precise tools like CRISPR? This isn’t about designing perfect babies; it’s about giving families the freedom to choose health over illness. Reproductive liberty includes the right to use science to safeguard life.

Third, innovation demands courage. Every major leap in medicine—from organ transplants to in vitro fertilization—was once deemed unnatural or dangerous. Today, we celebrate them as triumphs of human ingenuity. Gene editing is no different. Rather than retreat into fear, we must regulate wisely, research transparently, and move forward with humility and hope.

We are not playing God—we are becoming more humane. And in that pursuit, morality does not lie in stagnation, but in the courageous choice to heal.

Negative Opening Statement

Thank you. We oppose the motion because the moral risks of gene editing far outweigh its promises. While we acknowledge the allure of eradicating disease, we cannot ignore the Pandora’s box this technology opens—a box labeled “human perfection” that history has shown us leads to discrimination, inequality, and the erosion of what makes us fundamentally human.

Our first objection is rooted in human dignity. Human beings are not projects to be optimized. There is intrinsic value in the unaltered human genome—not because it is flawless, but because it represents the shared randomness of nature and the equality of chance. Once we begin editing embryos for non-therapeutic traits—intelligence, appearance, athleticism—we reduce persons to products, designed to specification. Is a child still a gift if they are a blueprint?

Second, the specter of eugenics looms large. In the 20th century, forced sterilizations and racial purity laws were justified in the name of genetic improvement. Today, market forces may achieve what totalitarian regimes once attempted: a new class divide between the genetically enhanced and the “naturals.” Imagine a world where access to genetic upgrades depends on wealth—where privilege begins not at birth, but before it. That is not progress. That is biological apartheid.

Finally, we face irreversible unknowns. Genes interact in complex networks; editing one trait may unknowingly affect others. These changes pass to future generations. Unlike a flawed policy or a failed drug, we cannot recall a modified gene from the human gene pool. The precautionary principle demands restraint when the stakes are nothing less than the future of our species.

Compassion should guide medicine—but so should wisdom. And wisdom tells us: just because we can do something, doesn’t mean we should.

Rebuttal of Opening Statement

Affirmative Second Debater Rebuttal

The opposition paints a haunting picture: eugenics, inequality, the loss of human dignity. They speak of “biological apartheid” and warn us we are opening Pandora’s box. But let’s be clear—what they’ve described is not gene editing; it’s misuse of gene editing. And the proper response to misuse is not abandonment—it is governance.

First, their argument against human dignity collapses under scrutiny. They claim there is sacred value in the “unaltered genome.” But if dignity lies in randomness, then every child born with a devastating genetic disease carries greater dignity than one spared by science. That is not reverence for life—it is romanticization of suffering. We do not diminish a person’s worth by preventing illness. We affirm it.

Second, the specter of eugenics they invoke is real—but it is not an inevitable outcome. Yes, history warns us of state-mandated breeding programs. But today, we regulate reproductive technologies with ethics boards, consent laws, and international guidelines. To reject all gene editing because someone might abuse it is like banning fire because it once burned down a village. The solution isn’t darkness—it’s light. Transparency. Oversight. Equity in access.

And let’s address the elephant in the room: they conflate therapeutic editing with cosmetic enhancement. No one here advocates designing babies with IQs off the charts or eyes like sapphires. The motion is about eliminating disease, not engineering superiority. To oppose curing cystic fibrosis because someone might later edit for height is like opposing seatbelts because cars could be used in bank heists.

Finally, their precautionary principle cuts both ways. Yes, changes are heritable. But so is untreated genetic suffering. Every generation inherits the mutations we fail to correct. Is it really more cautious to preserve harm than to prevent it?

We are not playing God. We are using tools we’ve discovered in nature—CRISPR comes from bacteria, after all—to fulfill medicine’s oldest promise: first, do no harm. And sometimes, doing no harm means acting boldly.

Negative Second Debater Rebuttal

The affirmative team speaks of duty, autonomy, and progress. They call us fearful for resisting what they see as inevitable. But courage is not measured by how fast we move—it’s measured by whether we know where we’re going.

They say we have a moral obligation to eliminate disease. Fine. Then let us focus on treatments for the living—not permanent alterations to future generations who cannot consent. Gene editing germline cells doesn’t just affect one patient; it rewrites the blueprint for countless descendants. Is it really “doing no harm” when we make decisions for people who don’t yet exist—and can never say yes or no?

On autonomy: they claim parents already make big choices. True. But choosing a child’s school is not the same as choosing their DNA. One shapes experience; the other determines biology before experience even begins. When parents select traits—even disease resistance—they begin treating children as projects with specifications, not persons with destinies. That subtle shift changes everything.

And let’s examine their historical analogy. They compare gene editing to vaccines and IVF. But those technologies healed individuals without altering the human lineage. IVF doesn’t change sperm or egg DNA. Vaccines don’t pass modifications to grandchildren. This is different. This is evolution by design. And once we start, where do we stop?

They dismiss our concerns about enhancement as “misuse,” but the line between therapy and enhancement is porous. Today, deafness is a disability. Tomorrow, it might be a cultural identity. Is editing out autism compassion—or erasure? Who decides what counts as a “disease”? If we give parents the right to remove genetic risks, we also give them the power to demand genetic advantages. And in a world of unequal resources, that power will belong only to the wealthy.

They say regulation will fix everything. But regulations lag behind technology. Look at social media: designed for connection, now fueling mental health crises. CRISPR moves faster than law. By the time we realize we’ve crossed a line, the edits will be in the gene pool—forever.

Compassion demands action, yes. But wisdom demands humility. Just because we can eliminate a gene doesn’t mean we understand its role fully. Genes are not isolated switches; they are part of vast, interacting networks. Editing one may silence another unintended trait—say, resilience to infection or emotional depth.

We are not opposed to science. We are demanding that science serve humanity—not redefine it. And if we lose the idea that every human life has value regardless of genetic perfection, then we have cured disease at the cost of our soul.

Cross-Examination

Affirmative Cross-Examination

Affirmative Third Debater:
To the first speaker of the negative team: You argue that gene editing threatens human dignity because it turns children into designed products rather than natural gifts. But if a mother takes folic acid during pregnancy to prevent neural tube defects, is she also designing a product?

Negative First Debater:
No, because that’s a general health measure, not a direct alteration of the genome.

Affirmative Third Debater:
So intent matters. Then tell me: if parents use gene editing solely to prevent Tay-Sachs disease — a fatal condition causing blindness, paralysis, and death by age five — and do so out of love and protection, how is their intent different from taking folic acid? Isn’t this still an act of care, not commodification?

Negative First Debater:
The difference lies in permanence and precision. Gene editing makes irreversible changes at the genetic level, affecting future generations without their consent.

Affirmative Third Debater:
Interesting. So you accept that intent isn’t the problem — it’s the tool. But earlier you said we risk creating “biological apartheid.” Let me ask the second speaker: If we ensure equitable access — say, through public healthcare funding — so that every child, rich or poor, can be edited to avoid cystic fibrosis, does that eliminate your concern about inequality?

Negative Second Debater:
Not entirely. Even with equal access, the normalization of editing creates social pressure to conform. Parents may feel compelled to edit not because they want to, but because society deems unedited children as “at-risk” or “lesser.”

Affirmative Third Debater:
Ah, so even perfect equity won’t satisfy your objection — because the mere existence of the technology alters social values. Then let me ask the fourth speaker: Suppose we never use gene editing for enhancement, only for lethal diseases, strictly regulated, universally accessible, and driven by medical necessity. Under those ideal conditions, would you still oppose it?

Negative Fourth Debater:
Yes. Because once we accept that human beings can be genetically modified before birth, we’ve crossed a moral threshold. The principle is violated, regardless of application.

Affirmative Third Debater:
So even if no child suffers, no inequality arises, and no enhancement occurs — you’d still forbid parents from sparing their child a painful, early death? That isn’t caution. That’s absolutism masquerading as ethics.

Pause.

Let me summarize. The negative side claims to stand for dignity, justice, and prudence. Yet under scrutiny, their stance collapses into contradiction. They condemn gene editing as unnatural — but accept other prenatal interventions. They fear inequality — but reject solutions involving access. And ultimately, they admit they would deny life-saving treatment even in a perfectly just, safe, and consensual world. This isn’t moral rigor — it’s moral paralysis. If compassion requires action, then refusing to act when we can prevent suffering is not wisdom. It is complicity in avoidable pain.

We asked them to draw a line between responsible use and abuse. They cannot — because their real objection isn’t with the practice, but with the possibility of human agency over our biology. But medicine has always been about mastering nature to protect life. From antibiotics to vaccines, we’ve reshaped biology to honor humanity. Gene editing is not its betrayal — it is its evolution.

Affirmative Cross-Examination Summary

The negative side’s position crumbles under focused questioning. Their core objections—dignity, inequality, and irreversibility—are either mischaracterized or inconsistently applied. They concede that intent matters, yet reject gene editing based on tool-type alone. They acknowledge the need for equity but resist any scenario where editing becomes normalized. Most damningly, they admit they would prohibit even hypothetical, perfect applications—revealing a philosophical stance rooted in prohibition, not precaution. This is not ethical rigor—it is refusal to engage with the human condition. The affirmative team demonstrated that moral responsibility includes both prevention and foresight—and that rejecting a powerful tool out of fear is itself a moral failure.

Negative Cross-Examination

Negative Third Debater:
To the first speaker of the affirmative team: You claim gene editing is a moral imperative to prevent disease. But who decides what counts as a disease? Is depression a disease? Homosexuality was once classified as one. Could your framework justify editing out traits later recognized as part of human diversity?

Affirmative First Debater:
We distinguish based on medical consensus. Conditions that cause severe suffering, disability, or early death — like Huntington’s — are clearly pathological. Diversity is not pathology.

Negative Third Debater:
Then you trust experts to define normalcy. But history shows those definitions change — and often reflect bias. Let me ask the second speaker: You dismissed enhancement as “misuse,” but isn’t intelligence linked to survival? If a child has a gene variant associated with lower cognitive function and higher risk of poverty, wouldn’t editing it be “therapeutic”? Where exactly do you draw the line?

Affirmative Second Debater:
The line is clinical severity. We focus on monogenic disorders with predictable, devastating outcomes — not polygenic traits influenced by environment and ethics.

Negative Third Debater:
Convenient. But genes don’t read your policy. Take the APOE4 gene — linked to Alzheimer’s. Editing it reduces disease risk, yes. But it’s also associated with creativity and immune resilience. If we eliminate it, might we unintentionally reduce human adaptability? Do you accept that editing for health could weaken us in ways we don’t yet understand?

Affirmative Second Debater:
All medicine involves risk-benefit analysis. We proceed cautiously, with research.

Negative Third Debater:
Fair. Then let me ask the fourth speaker: Germline editing affects not just one person, but all their descendants. These future individuals cannot consent to having their DNA altered. How is it ethical to make irreversible decisions for people who don’t yet exist?

Affirmative Fourth Debater:
We make decisions for future generations all the time — climate policy, education funding, constitutional laws. Why is genetic inheritance uniquely off-limits?

Negative Third Debater:
Because those are societal choices, not biological rewrites. Laws can be changed. Genes passed down cannot. If a future generation discovers that edited ancestors lost empathy or musicality due to a “correction” we thought was beneficial — who apologizes? Who bears responsibility?

Pause.

Our questions reveal a dangerous optimism in the affirmative case — one that underestimates complexity and overestimates control. They speak of “therapy” as if it exists in a vacuum, untouched by social forces or scientific uncertainty. But medicine doesn’t operate in isolation. It operates within culture, power, and evolving definitions of normalcy.

They claim we can separate therapy from enhancement — but the boundary is porous, shifting, and historically abused. They believe regulation can contain misuse — yet CRISPR is already available in DIY biohacker kits. And they compare germline editing to public policy — but no law alters the biological essence of millions unborn.

Most troublingly, they offer no mechanism for accountability when things go wrong across generations. Unlike a failed drug trial, there’s no recall for a flawed gene drive. Once released, it replicates — silently, endlessly.

Their vision is one of mastery: humans as engineers of life. Ours is one of humility: stewards of a shared genetic heritage. One leads to healing; the other, to hubris. We don’t reject science — we demand that science remember its limits. Because the right to edit genes must never outweigh the right to be born unedited — free from design, free from expectation, free to become who you are, not who your parents decided you should be.

Negative Cross-Examination Summary

The affirmative team’s responses revealed a fundamental disconnect between theoretical ideals and practical consequences. They offered no clear definition of “therapy” beyond medical consensus—which is fluid—and admitted that gene editing might inadvertently harm traits we haven’t yet understood. Worse, they failed to provide a mechanism for holding future generations accountable for irreversible changes. Their reliance on regulation as a panacea ignores the speed of technological diffusion and the inevitability of misuse. Ultimately, the negative team exposed a critical flaw: the affirmative assumes that because we can edit genes, we must. But the question remains: should we? The answer, grounded in intergenerational ethics, is no.

Free Debate

Affirmative First Debater:
You say we shouldn’t edit genes because future generations can’t consent. But neither did they consent to inherit Huntington’s disease. We don’t refuse chemotherapy because patients didn’t choose cancer. If silence means approval, then letting children suffer genetic agony is our loudest endorsement.

Negative First Debater:
And yet you’re not just treating disease—you’re rewriting the book of life before the first page is written. There’s a difference between healing a wound and redesigning the body it belongs to. One respects the patient; the other assumes perfection lies in code.

Affirmative Second Debater:
Perfection? We’re talking about stopping babies from dying at five from spinal muscular atrophy. Is that “redesign”? Or is it basic medicine dressed up as dystopia by fear?

Negative Second Debater:
We’re not afraid of curing SMA—we’re afraid of normalizing germline edits so thoroughly that not editing becomes seen as child neglect. Imagine schools asking, “Why didn’t your parents fix your ADHD gene?” That’s not medicine. That’s coercion through biology.

Affirmative Third Debater:
So your solution is to ban all editing because some people might feel social pressure? By that logic, we should ban glasses because kids get teased for needing them—or worse, praised for not needing them. Should we outlaw vaccines so no parent feels judged for refusing one?

Negative Third Debater:
Vaccines protect against infection. Gene editing alters identity. One fights viruses; the other reshapes what it means to be human. You can’t compare public health to permanent species-level changes made without consent.

Affirmative Fourth Debater:
Then let me ask: if a gene causes 100% fatal neurodegeneration by age ten, and we can remove it with CRISPR—no off-target effects, full safety—would you still say, “Let nature take its course”? That’s not humility. That’s surrender disguised as principle.

Negative Fourth Debater:
We wouldn’t oppose removing such a gene—if it were somatic. But germline editing forces every descendant to carry that change. It turns medicine into eugenics by stealth: well-meaning today, irreversible tomorrow. Once edited, always edited. Even when we realize we were wrong.

Affirmative First Debater (interjecting):
Ah, now we’re told somatic editing is fine—but germline isn’t. So you accept editing cells in a living child but reject preventing the disease altogether? That’s like applauding firefighters while banning smoke detectors!

(Audience chuckles)

Negative First Debater:
Except smoke detectors don’t pass their settings down to your grandchildren. Every germline edit is a forever decision made by today’s scientists for unborn millions. Who gave us that authority?

Affirmative Second Debater:
Nature gives it to us—through discovery. We didn’t invent DNA repair; we observed it in bacteria. CRISPR is natural intelligence harnessed by human reason. To call this “playing God” is to misunderstand both science and morality.

Negative Second Debater:
And to call it “natural” is to ignore that we’re using bacterial defense systems to design humans like software updates. Soon we’ll have patches for shyness, upgrades for memory. What happens when someone releases a bug?

Affirmative Third Debater:
Then we fix it—like any technology. Planes crashed in 1903. Now they’re the safest way to travel. You don’t ground aviation because early models failed. You regulate, improve, and move forward—with care.

Negative Third Debater:
But when a plane crashes, only passengers die. When a gene edit fails, it could echo through centuries. Mistakes in the genome aren’t recalled; they replicate. Do you want apologies carved into the human lineage?

Affirmative Fourth Debater:
And do you want tombstones carved with “Could’ve been saved, but ethics committee was cautious”? Compassion delayed is compassion denied. Every year we stall, thousands are born into preventable torment.

Negative Fourth Debater:
Torment? Or variation? Autism once called “refrigerator mother syndrome.” Homosexuality listed as mental illness until 1973. Today’s defect may be tomorrow’s diversity. Who decides which genes deserve eradication?

Affirmative First Debater:
No one said eradicate autism. We said eliminate lethal monogenic disorders—single-gene killers like Tay-Sachs. Don’t conflate clarity with chaos. We draw lines. Society does it daily: we vaccinate, we medicate, we operate. Why freeze progress here?

Negative First Debater:
Because vaccines don’t make your great-grandchildren immune without their say. Consent isn’t just personal—it’s intergenerational. Editing embryos treats future people like passive data streams, not autonomous beings.

Affirmative Second Debater:
Funny—because those same future people will thank us when they’re not gasping for breath from cystic fibrosis. You speak of autonomy, but deny it to the child who never gets to choose life over death.

Negative Second Debater:
Autonomy begins with existence. But if your very DNA was chosen by others, how free are you really? Are you a person—or a product review waiting to happen?

Affirmative Third Debater:
Now you’re saying love is consumerism. A mother taking folic acid is “designing” her baby. A father avoiding radiation is “optimizing” sperm. At what point does responsible parenting become unethical engineering?

Negative Third Debater:
When the intervention crosses from environment to essence. Folic acid supports development. Gene editing dictates destiny. One nurtures chance; the other eliminates it.

Affirmative Fourth Debater:
So randomness is sacred? Then why treat infertility? Why use prenatal screening? Why celebrate any medical advance that improves odds? Your reverence for chance sounds suspiciously like resignation.

Negative Fourth Debater:
It’s called humility. Knowing when power exceeds wisdom. Fire gave us warmth—and wildfires. Nuclear energy powers cities—and bombs. Just because we unlock a mechanism doesn’t mean we should deploy it recklessly on our own species.

Affirmative First Debater:
Reckless? You keep saying that, but offer no evidence of risk beyond hypothetical horror stories. Meanwhile, real children suffer. Real families grieve. And you’d rather philosophize than intervene?

Negative First Debater:
We’re not refusing action—we’re demanding deliberation. Speed is not virtue. Progress without guardrails isn’t liberation; it’s a high-speed crash in slow motion.

Affirmative Second Debater:
Deliberation is good. Eternal hesitation is not. We’ve had decades of bioethics panels, WHO guidelines, international summits. The world isn’t rushing blindly—we’re walking carefully into light, not leaping into darkness.

Negative Second Debater:
Carefully? Then explain He Jiankui—the scientist who edited twins for HIV resistance with shaky science and zero oversight. That wasn’t caution. That was curiosity unchained. And he won’t be the last.

Affirmative Third Debater:
Exactly! So punish the rogue actor—not ban the tool. We don’t abolish surgery because one doctor operated drunk. We license, monitor, enforce. Same model applies.

Negative Third Debater:
But licenses can be forged. Oversight can be evaded. And once edited embryos are born, the genie’s out. Regulation follows innovation—it doesn’t lead it. CRISPR is already in backyard labs. Can you really control what you can’t contain?

Affirmative Fourth Debater:
Then strengthen global norms. Ban germline editing where unsafe. Allow it where ethical and regulated. Uniformity isn’t the enemy—principled pluralism is the path forward.

Negative Fourth Debater:
Principled pluralism? Or patchwork permission slips for the rich to enhance while the poor stay “natural”? Call it what it is: a new axis of inequality, coded in DNA.

Affirmative First Debater:
Then fight inequality—not science. Don’t punish breakthroughs because society fails to distribute them fairly. That’s like banning computers because not everyone has Wi-Fi.

Negative First Debater:
Computers don’t redefine humanity. Genes do. And until we can guarantee equity, foresight, and reversibility, pressing “edit” on the human blueprint is not courage—it’s arrogance wrapped in altruism.

Strategic Rhythm and Team Dynamics

This exchange exemplifies the core functions of free debate: offense and defense intertwined, ideas tested under fire, and rhetoric sharpened by opposition.

The affirmative team maintained momentum by anchoring every argument in tangible suffering and medical necessity. They effectively used analogy (vaccines, fire, aviation) to normalize gene editing within existing ethical frameworks. Their humor—especially the "smoke detector" line—lightened tone without sacrificing substance, making complex ideas accessible.

The negative team, meanwhile, elevated the discussion beyond immediate benefits to long-term existential risks. They successfully reframed the debate from “can we heal?” to “should we redesign?”—shifting the burden of proof onto the affirmative to justify permanence and consent. Their strongest weapon was the specter of unintended legacy: edits echoing across generations.

Both sides demonstrated strong coordination:
- The affirmatives cycled speakers to reinforce key themes (duty, safety, precedent).
- The negatives built layered resistance, moving from ethics to practicality to identity.
- Each rebuttal targeted not just content but underlying assumptions—e.g., challenging the definition of “therapy” versus “enhancement.”

Crucially, neither side resorted to caricature. They engaged the strongest versions of opposing arguments, raising the intellectual stakes. This is what separates mature debate from mere disagreement.

Ultimately, the clash centered on two visions of humanity:
- One sees gene editing as the next step in compassionate evolution.
- The other sees it as a rupture in the moral fabric of human continuity.

Neither position is easily dismissed. But in this round, the most compelling moments arose when debaters acknowledged complexity—when they said, “Yes, and…” instead of “No, but…”

That’s the hallmark of excellence: not victory at all costs, but truth pursued with rigor, respect, and a touch of wit.

Closing Statement

Affirmative Closing Statement

Ladies and gentlemen, esteemed judges—this debate has never been about creating superhumans or designing perfect babies. That is a caricature, not a reality. What we have discussed today is far simpler, yet infinitely more profound: Can we prevent unbearable suffering when we have the power to do so?

From the very beginning, we’ve stood on four unshakable pillars. First—the duty to heal. We already accept vaccines, surgeries, and medications that alter biology to save lives. Gene editing is not a break from medicine’s tradition; it is its boldest continuation. To deny a child freedom from cystic fibrosis because we fear the word “editing” is not prudence—it is paralysis masked as principle.

Second—the right to choose. Parents make life-shaping decisions every day. Nutrition, education, environment—all influence a child’s future. Why should the most fundamental choice—whether to pass on a deadly mutation—be forbidden? This isn’t playing God. It’s parenting with foresight. And if we truly believe in reproductive autonomy, then that autonomy must include the tools science provides.

Third—the inevitability of progress. Every breakthrough—from blood transfusions to IVF—was once called unnatural. People said we were “tampering with life.” But history does not remember the skeptics; it honors those who dared to cure. Today, CRISPR is not science fiction. It’s in labs. It’s in trials. The question is not if we will use it—but how wisely we will guide it.

And fourth—the risk of doing nothing. The negative side speaks of unintended consequences. But let us be honest: there are also consequences to inaction. Every year we delay, thousands are born into pain we could have prevented. Every generation inherits the same broken genes we had the power to fix—but didn’t. Is that caution? Or is it complicity?

They warn of a slippery slope. But slopes can be guarded. We regulate nuclear energy—not because it’s inherently evil, but because it demands responsibility. So too with gene editing. With ethics boards, international standards, and equitable access, we can walk this path without falling.

We are not asking for reckless experimentation. We are calling for compassionate innovation. For a world where no parent must watch their child suffocate from a disease written in their DNA. For a future where medicine doesn’t stop at birth—but begins before it.

So let us not fear the light of knowledge. Let us hold it high. Because sometimes, the most moral act is not restraint—but courage.
Therefore, we firmly believe: yes, it is morally acceptable—and profoundly necessary—to use gene editing technologies on humans.

Negative Closing Statement

Thank you, judges.

Throughout this debate, the affirmative has spoken of cures, of compassion, of progress. And we do not doubt their intentions. But good intentions have paved many roads to ruin. What matters is not just what we aim to do—but what we become in the process.

At the heart of our opposition lies a simple truth: some doors, once opened, cannot be closed. Gene editing—especially germline editing—does not just change one life. It alters the human lineage. It writes new code into the story of our species. And we are being asked to approve this… without knowing how the story ends.

We have heard comparisons to vaccines and seatbelts. But those interventions protect individuals without rewriting evolution. Gene editing passes changes down forever. Future generations will carry our choices in their bones—and they cannot consent. Is it ethical to make permanent decisions for people who don’t yet exist? If we would not force a religion or ideology on unborn children, why would we impose a genome?

The affirmative says we can draw a line between therapy and enhancement. But lines blur. Today, we edit out Tay-Sachs. Tomorrow, we eliminate depression. Then shyness. Then low IQ. Who defines what is a “disease”? History shows us: power does. And in a world of inequality, genetic privilege will follow wealth. The rich won’t just live longer—they’ll be smarter, stronger, more resilient. And the rest? Left behind not by chance, but by design.

They say regulation will protect us. But regulations fail. Technology outpaces law. Look at AI, social media, data harvesting—every time, we react after the damage is done. CRISPR moves faster than policy. By the time we realize we’ve commodified human life, it may be too late to reverse.

And beyond the risks—there is a deeper loss. The loss of wonder. The loss of acceptance. There is beauty in the unplanned, the unexpected, the imperfect. When we treat every genetic variation as a defect to be corrected, we send a message: you are only valuable if you are optimized. But humanity is not a machine. It is a symphony of differences—some painful, yes, but all part of what makes us who we are.

We are not against science. We are against hubris. Against the belief that we can engineer away suffering without engineering away something essential in ourselves.

Compassion does not require conquest. We can care for those with genetic conditions without erasing them. We can advance medicine without redefining humanity.

So let us slow down. Let us ask not just can we, but should we? Let us value the child not as a project to perfect, but as a person to welcome—with all their unpredictability, fragility, and grace.

Because in the end, the greatest threat to our humanity may not be disease… but the belief that we can—and must—perfect it.

Therefore, we stand firm: it is not morally acceptable to use gene editing technologies on humans—because some boundaries exist not to limit progress, but to preserve our soul.